EPIX

ESSA Pharma
EPIX

Overview Fund Trends Analyst Outlook
Delisted

EPIX was delisted on the 8th of October, 2025.

Back to rankings

60 hedge funds and large institutions have $530M invested in ESSA Pharma in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-15
Holders Change %
-20%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
25
Reduced
19
Closed
21
Calls
$171K
Puts
$9K
Net Calls
+$162K
Net Calls Change
+$162K

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$16.2M
2
SCM
Soleus Capital Management
Connecticut
+$9.34M
3
WP
Woodline Partners
California
+$7.2M
4
ACM
Altium Capital Management
New York
+$4.9M
5
CS
Candriam SCA
Luxembourg
+$4.63M

Top Sellers

1
Two Sigma Investments
Two Sigma Investments
New York
-$6.89M
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$5.8M
3
VC
Vivo Capital
California
-$4.43M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.86M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.57M
Name Holding Trade Value Shares
Change 		Shares
Change %
LC
76
Lindbrook Capital
California
– -$6K -750 Closed
HI
77
Harbour Investments
Wisconsin
– -$2K -300 Closed
EWA
78
Evolution Wealth Advisors
Florida
– -$2K -287 Closed
RE
79
RBC Europe
United Kingdom
– -$1.42K -178 Closed
1 2 3
4